Gastro-entero-pancreatic hormones in amniotic fluid from normal and diabetic pregnant women.
Clinical applications of analyses of hormones in amniotic fluid (AF) have recently been increased. In diabetic pregnancy, determinations of insulin and C-peptide in AF have been suggested as good indicators of the status of the foetus. We have investigated the pancreatic alpha and beta cell function by measuring insulin (IRI), C-peptide (CPR), glucagon (IRG), somatostatin (SLI), and gastric inhibitory polypeptide (GIP) in amniotic fluid collected during basal conditions or 2 h after an arginine test in 92 diabetic and 32 non-diabetic pregnant women. During basal conditions, in diabetic pregnant women, IRI, CPR and the insulin: glucagon molar ratio (I/G) were all significantly higher while amniotic fluid-IRG was significantly lower than in the controls. After arginine stimulation, IRI increased in AF of the diabetic pregnant women but not in AF of the controls while no differences were observed in AF-GIP and AF-SLI concentrations. Higher IRI and CPR, as well as lower IRG values were significantly related to poor maternal metabolic control. The occurrence of neonatal morbidity including macrosomia was significantly associated with increased AF, IRI and CPR concentrations after an arginine challenge and these factors were the most sensitive predictors of neonatal morbidity in infants of diabetic mothers. Increased AF glucose concentrations and I/G ratios were related to neonatal hypoglycaemia; jaundice and respiratory distress syndrome were associated to low concentrations of SF-IRG.
D000653:Amniotic Fluid / Q000032:analysis*; D001120:Arginine; D002096:C-Peptide / Q000032:analysis; D005260:Female; D005749:Gastric Inhibitory Polypeptide / Q000032:analysis; D005768:Gastrointestinal Hormones / Q000032:analysis*; D005934:Glucagon / Q000032:analysis; D005947:Glucose / Q000032:analysis; D006801:Humans; D007328:Insulin / Q000032:analysis; D010455:Peptides / Q000032:analysis; D011247:Pregnancy / Q000378:metabolism*; D011254:Pregnancy in Diabetics / Q000378:metabolism*
D002096:C-Peptide; D005768:Gastrointestinal Hormones; D007328:Insulin; D010455:Peptides; C029993:somatostatin-like peptides; D005749:Gastric Inhibitory Polypeptide; D005934:Glucagon; D001120:Arginine; D005947:Glucose